Previous 10 | Next 10 |
gammaCore to treat asthma in coronavirus infected patients. The U.S. Food and Drug Administration (FDA) authorized the use of gammaCore for the treatment of asthma exacerbations in known or suspected COVID-19 patients. The shares of gammaCore gained over 100% value upon the emergency use authori...
Gainers: Equillium (NASDAQ: EQ ) +220% . More news on: Equillium, Inc., electroCore, Inc., WiMi Hologram Cloud Inc., Stocks on the move, , Read more ...
Penny Stocks To Watch With Analyst Buy Ratings Despite their volatility, penny stocks are continuing to attract interest from investors this year. For the most part, anyone trading these cheap stocks understands that these can move very quickly. That’s one of the big reasons why I thi...
BASKING RIDGE, N.J., July 13, 2020 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced that the FDA has issued an Emergency Use Authorization (EUA) authorizing the use of gammaCore Sapphire™ CV non-invasive vag...
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. A podcast of Stocks to Watch is also available on Sundays on Seeking Alpha , Apple ...
BASKING RIDGE, N.J., July 09, 2020 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, announced today that Dan Goldberger, Chief Executive Officer, will participate in three upcoming investor conferences: Maxim Group/M-Vest COVI...
Opiant Pharmaceuticals (NASDAQ: OPNT ) -32% after Teva prevails in Narcan patent dispute . More news on: Opiant Pharmaceuticals, Inc., Ascena Retail Group, Inc., Ekso Bionics Holdings, Inc., Stocks on the move, , Read more ...
BASKING RIDGE, N.J., May 29, 2020 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced that that a prerecorded virtual presentation featuring Dan Goldberger, Chief Executive Officer, will be available at Little Grapevi...
Investment Thesis electroCore share price performance since IPO. Source: TradingView . electroCore (NASDAQ: ECOR ) has been a crushing disappointment for its investors since its June 2018 IPO. Despite the promise of its FDA approved, non-invasive treatment for migraines - gammaCore - cl...
Cassava Sciences (NASDAQ: SAVA ) -82% after Alzheimer's candidate flunks mid-stage study. More news on: Cassava Sciences, Inc., Synthesis Energy Systems, Inc., Creative Realities, Inc., Stocks on the move, , Read more ...
News, Short Squeeze, Breakout and More Instantly...
ROCKAWAY, N.J., May 03, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc. (the “Company”), (NASDAQ: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced that on May 1, 2024, Donald Melnikoff joined electroCore as the Company’s SVP, Engineering, Regu...
ROCKAWAY, N.J., May 01, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc. (NASDAQ:ECOR), a commercial-stage bioelectronic medicine and wellness compan...
ROCKAWAY, N.J., May 01, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced that it will report financial results for the first quarter ended March 31, 2024, after the close of the market on Wednesday...